DOI: 10.1055/s-00032260

Digestive Disease Interventions

References

Fukuoka S, Hara H, Takahashi N. et al.
Regorafenib plus nivolumab in patients with advanced gastric (GC) or colorectal cancer (CRC): an open-label, dose-finding, and dose-expansion phase 1b trial (REGONIVO, EPOC1603).

J Clin Oncol 2019;
37: 2522-2522

Download Bibliographical Data

Search in:
Access: